TABLE 5.
Compound | Structural class | Ribosomal subunit specificity | Signal (%) at concna (μg/ml) of:
|
|||
---|---|---|---|---|---|---|
12.5 | 6.25 | 3.13 | 1.56 | |||
yheI biomarker-inducing compounds | ||||||
Chloramphenicol | 50S | 140 | 440 | 840 | 570 | |
Tylosinb | 16-Membered macrolide | 50S | 880 | 490 | 340 | 200 |
Viridogriseinb | Streptogramin B type | 50S | 180 | 430 | 520 | 110 |
Pristinamycin 1Cb | Streptogramin B type | 50S | 10 | 20 | 160 | 470 |
Mikamycin A | = Streptogramin A | 50S | 150 | 350 | 520 | 350 |
Sparsomycin | 50S | 240 | 180 | 150 | 120 | |
Thiostrepton | Thiopeptide | 50S | 380 | 190 | 160 | 110 |
Thiopeptin B | Thiopeptide | 50S | 210 | 130 | 110 | 100 |
A10255J | Thiopeptide | EF-Tu?c | 20 | 20 | 90 | 200 |
Althiomycin | 50S | 360 | 270 | 230 | 200 | |
Cephalosporin P1 | Steroid | EF-G | 10 | 30 | 190 | 290 |
Helvolic acid | Steroid | EF-G | 250 | 170 | 140 | 120 |
Bamicetin | Amicetin-type nucleoside | 50S | 370 | 250 | 190 | 150 |
Amicetin | Amicetin-type nucleoside | 50S | 330 | 190 | 270 | 130 |
Pleuromutilin | 50S | 200 | 340 | 110 | 230 | |
Hygromycin A | 50S | 240 | 160 | 170 | 140 | |
Oxytetracycline | Tetracycline | 30S (50S) | 20 | 100 | 440 | 480 |
Ferrimycin A1d | Sideromycin | Unknown | 20 | 30 | 440 | 770 |
Trinactine | Polynactin | 650 | 210 | 190 | 130 | |
Noninducing protein biosynthesis inhibitors of the natural product library | ||||||
Actinoninf | 120 | 80 | 85 | 90 | ||
Streptomycing | Aminoglycoside | 30S | 88 | 89 | 100 | 95 |
Puromycin | Aminoacyl-adenosine analogue | 50 | 80 | 101 | 110 | |
Fusidic acidh | Steroid | EF-G | 20 | 20 | 20 | 20 |
Siomycin Ah | Thiopeptide | 50S | 20 | 20 | 20 | 30 |
Luminescence data measured during hit confirmation at four different compound concentrations between 1.56 and 12.5 μg/ml. Values represent percentages of the noninduced biomarker signal. In a case where a value is above 200% (bold numbers), the biomarker system is considered to be induced. Underlined values (below 50%) indicate antibiotic effects during cell incubation.
Three screening hits represented tylosins, and three additional ones were viridogriseins. Due to a plasmid-encoded resistance determinant in the biosensor cell, yheI marker induction by 14-membered macrolides, such as erythromycin, by lincomycin, or by streptogramin B cannot be expected. Nevertheless, close congeners of streptomycin B do indeed induce the biomarker.
A related compound (GE2270A) binds to EF-Tu.
Ferrimycin consists of a siderophore carrier and a probable bioactive moiety. Only limited data are available concerning its antibiotic MOA. yheI marker induction indicates that ferrimycin might indeed inhibit protein biosynthesis.
Trinactin is known to interfere with biomembranes by acting as an ionophore.
Actinonin inhibits the peptide deformylase, an essential enzyme involved in the posttranslational processing of proteins.
Besides streptomycin, the aminoglycosides gentamicin, kanamycin, and neomycin also do not induce the yheI biomarker. Only spectinomycin, which in contrast to the other aminoglycosides does not cause misreading during translation, induces the biomarker at high concentrations (25 μM).
Fusidic acid and siomycin A are indeed inducing agents below 1.56 μg/ml. At screening concentrations above 1.56 μg/ml, they already inhibit bacterial growth and repress the luciferase signal.